Picornaviridae Infections  >>  Vanihep (vaniprevir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vanihep (vaniprevir) / Merck (MSD)
NCT00704184 / 2008-000149-72: Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007)

Completed
2
95
NA
Comparator: Vaniprevir, MK-7009, Comparator: Pegylated-Interferon (Peg-IFN), Comparator: Ribavirin, Comparator: placebo
Merck Sharp & Dohme LLC
Hepatitis C
12/08
04/10
NCT00880763: A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)

Checkmark
Aug 2014 - Aug 2014: 
Completed
2
90
NA
Vaniprevir, MK7009, Pegylated Interferon (peg-IFN), Ribavirin, Comparator: Placebo
Merck Sharp & Dohme LLC
Hepatitis C
06/10
02/12
NCT00704405 / 2008-000150-12: Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)

Checkmark EASL 2014
Mar 2014 - Mar 2014: EASL 2014
Checkmark
Oct 2013 - Oct 2013: 
Checkmark APASL 2013
More
Completed
2
285
NA
Vaniprevir, MK-7009, Pegylated Interferon (Peg-IFN), PEGASYS™, Ribavirin (RBV), COPEGUS™, Placebo (PBO)
Merck Sharp & Dohme LLC
Hepatitis C, Chronic
03/12
09/12
NCT00895882: Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

Withdrawn
2
0
US
vaniprevir (MK7009), Comparator: vaniprevir (MK7009), Comparator: Pegylated Interferon (peg-IFN) alfa-2a, Comparator: Ribavirin, Comparator: Placebo to vaniprevir
Merck Sharp & Dohme LLC
Chronic Genotype 1 Hepatitis C Virus Infection
01/13
01/13

Download Options